Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Clinical trial NCT03087760 · COMPLETED
Trial details
- NCT number
- NCT03087760
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2023-09-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.